Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10% Dextrose vs Triamcinolone as Adjuvant to PRF in Herniated Nucleus Pulposus
NCT07757321Completed
- Sponsor
- Universitas Indonesia
- Start
- Dec 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of dextrose in herniated nucleus pulposus (HNP) (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Numeric Rating Scale at 14 days. Started Dec 2025; status: completed.
02
Drugs
dextrose
03
Conditions
herniated nucleus pulposus (HNP)
Beyond the preview
Go deeper on NCT07757321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07757321.